Loading…
SBC Medical Group Holdings Incorporated is projected to rise to $3.35 by 2027, a +13% move from its current price of $2.97. SBC is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/12/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $2.90 | $2.97 | $3.05 | +0.04% |
| Jul 14 | $2.87 | $2.97 | $3.08 | +0.08% |
| Jul 15 | $2.85 | $2.97 | $3.11 | +0.11% |
| Jul 16 | $2.83 | $2.97 | $3.13 | +0.15% |
| Jul 17 | $2.81 | $2.98 | $3.15 | +0.19% |
| Jul 18 | $2.80 | $2.98 | $3.17 | +0.23% |
| Jul 19 | $2.79 | $2.98 | $3.18 | +0.26% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $2.79 | $2.98 | $3.18 | +0.26% |
| Week 2 | $2.72 | $2.99 | $3.28 | +0.53% |
| Week 3 | $2.67 | $2.99 | $3.36 | +0.80% |
| Week 4 | $2.63 | $3.00 | $3.43 | +1.06% |
| Week 5 | $2.59 | $3.01 | $3.49 | +1.33% |
| Week 6 | $2.56 | $3.02 | $3.55 | +1.60% |
| Week 7 | $2.54 | $3.03 | $3.61 | +1.87% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
SBC Medical Group Holdings Incorporated operates in the Industrials sector, providing management services to cosmetic treatment centers in Japan, Vietnam, the United States, and Singapore. Its offerings include advertising and marketing services across social media networks; staff management services, such as recruitment and training; booking reservations for franchisee clinic customers; assistance with franchisee employee housing rentals; leasehold improvement services; and design services for clinics, medical equipment, and medical consumables procurement. It also provides loyalty program management, labor and function supporting, and management consulting services; IT software solutions; franchising activities; and distributes medical equipment and devices, implants, injection materials, other medical consumables, skin care and beauty products, and cosmetic products to franchisee clinics for resale to clinic customers.
In addition, the company offers surgical and non-surgical surgeries that include breast augmentation; liposuction; rejuvenation treatments; laser skin toning and spot removal; eyes double fold surgery; rhinoplasty; laser hair removal; and other procedures. It owns and operates treatment centers under the SBC brand. SBC Medical Group Holdings Incorporated was founded in 2000 and is headquartered in Irvine, California.
SBC Medical Group Holdings Incorporated (SBC) is currently priced at $3.18 with a market cap of $326.19M and a rank of 3415. The stock trades in the Industrials niche and sits near key moving averages, reflecting a nuanced price position.
A major floor 11.9% below — a decisive break under it would weaken the trend.
The nearest floor, 3.4% below — buyers have tended to step in here.
The nearest ceiling, 11.1% above — a clean break opens room to run.
A major ceiling 52.5% above — clearing it would confirm fresh momentum.
Key SBC support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of SBC market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $2.99 | Sell | $3.01 | Sell |
| MA 10 | $3.09 | Sell | $3.04 | Sell |
| MA 20 | $3.05 | Sell | $3.06 | Sell |
| MA 50 | $3.10 | Sell | $3.20 | Sell |
| MA 100 | $3.52 | Sell | $3.44 | Sell |
| MA 200 | $3.78 | Sell | $3.81 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 43.88 | Neutral |
| Stoch RSI (14) | 12.90 | Buy |
| CCI (20) | -58.65 | Neutral |
| Williams %R (14) | -94.29 | Info |
| MACD (12,26,9) | -0.01 | Sell |
| ROC (12) | -3.26 | Sell |
| Bollinger %B (20,2) | 0.32 | Neutral |
| Stochastic %K (14) | 5.71 | Buy |
| TRIX (15) | -0.09 | Sell |
| Awesome (5,34) | -0.08 | Sell |
| Ultimate (7,14,28) | 41.44 | Neutral |
| Momentum (10) | -0.21 | Sell |
| Aroon Osc (25) | 36.00 | Buy |
| Hull MA (9) | 2.92 | Buy |
| ADX (14) | 13.73 | Neutral |
| ATR (14) | 0.07 | Info |
The 30-day technical picture is NEUTRAL, with RSI14 at 50. The 50-day simple moving average is $3.23 and the 200-day simple moving average is $3.85. The 30-day price range runs from $2.69 to $3.76, providing a modest trading band.
Support is at $2.87 and resistance at $3.23, highlighting a confined near-term path. The annualized volatility stands at 50%, underscoring substantial but not extreme swings within the month.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $2.87 | $2.97 | $4.02 | 0% | Neutral | |
| $2.69 | $3.35 | $4.41 | +13% | Neutral | |
| $2.89 | $3.70 | $5.04 | +25% | Bullish | |
| $2.69 | $3.51 | $4.91 | +18% | Neutral | |
| $2.62 | $3.48 | $4.99 | +17% | Neutral | |
| $3.06 | $4.15 | $6.05 | +40% | Bullish | |
| $3.40 | $4.67 | $6.95 | +57% | Bullish | |
| $3.58 | $5.00 | $7.55 | +68% | Bullish | |
| $3.60 | $5.09 | $7.81 | +71% | Bullish | |
| $3.48 | $5.00 | $7.77 | +68% | Bullish | |
| $4.80 | $7.31 | $12.05 | +146% | Bullish | |
| $8.02 | $13.54 | $24.29 | +356% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $2.87 | $2.97 | $3.64 | +0.00% |
| August 2026 | $2.65 | $3.12 | $3.77 | +5.00% |
| September 2026 | $2.59 | $3.07 | $3.75 | -1.43% |
| October 2026 | $2.61 | $3.11 | $3.83 | +1.33% |
| November 2026 | $2.69 | $3.22 | $3.99 | +3.29% |
| December 2026 | $2.68 | $3.22 | $4.02 | +0.12% |
Click any year to see its month-by-month SBC forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, SBC could reach as high as $4.02, with a base case around $2.97 and support toward $2.87 — roughly 0% from $2.97. A consolidation phase looks the most probable path here.
Expect SBC to range from $2.69 to $4.41 through 2027. The $3.35 average target implies a +13% move from current prices. That is up +13% on the projected 2026 average. Price action looks broadly range-bound.
The SBC price prediction for 2028 points to an average of $3.70 (low $2.89, high $5.04) — a potential gain of +25% on today's $2.97. Buyers look set to stay in control over this stretch.
In 2029, SBC is projected to trade between $2.69 and $4.91, averaging $3.51 — a potential gain of +18% from today's $2.97. That is -5% versus the projected 2028 average. Price action looks broadly range-bound.
SBC Medical Group Holdings Incorporated's 2030 outlook centres on $3.48, within a $2.62 to $4.99 range. That is -1% versus the projected 2029 average. That marks a +17% change versus current levels. A consolidation phase looks the most probable path here.
By 2031, SBC could reach as high as $6.05, with a base case around $4.15 and support toward $3.06 — roughly +40% from $2.97. Momentum favours further upside here.
Expect SBC to range from $3.40 to $6.95 through 2032. The $4.67 average target implies a +57% move from current prices. That is up +13% on the projected 2031 average. Buyers look set to stay in control over this stretch.
The SBC price prediction for 2033 points to an average of $5.00 (low $3.58, high $7.55) — a potential gain of +68% on today's $2.97. Momentum favours further upside here.
In 2034, SBC is projected to trade between $3.60 and $7.81, averaging $5.09 — a potential gain of +71% from today's $2.97. That is up +2% on the projected 2033 average. Buyers look set to stay in control over this stretch.
SBC Medical Group Holdings Incorporated's 2035 outlook centres on $5.00, within a $3.48 to $7.77 range. That is -2% versus the projected 2034 average. That marks a +68% change versus current levels. Momentum favours further upside here.
By 2040, SBC could reach as high as $12.05, with a base case around $7.31 and support toward $4.80 — roughly +146% from $2.97. Buyers look set to stay in control over this stretch.
Expect SBC to range from $8.02 to $24.29 through 2050. The $13.54 average target implies a +356% move from current prices. That is up +85% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in SBC today (≈ 336.700337 SBC) could be worth
$4,557.35
+$3,557.35 (+356%) by 2050 · US Dollar
Based on the average projected SBC price of $13.54 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in SBCwould be worth at today's price.
$1,000 invested in SBC on Jul 10, 2025 (≈ 187.617263 SBC) would be worth
$557.22
-$442.78 (-44.3%) today · 0.56× · US Dollar
Based on a SBC entry price of $5.33 vs. today's $2.97.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $3.25 | $913.85 | -8.6% |
| 1 month ago | $3.02 | $983.44 | -1.7% |
| 3 months ago | $4.15 | $715.66 | -28.4% |
| 6 months ago | $4.47 | $664.43 | -33.6% |
| 1 year ago | $5.33 | $557.22 | -44.3% |
| All time (3.8y) ago | $9.96 | $298.19 | -70.2% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our SBC forecast.
Our base-case forecast reaches $5.90 around 2040.
Implied market cap at $5.90: $605.2M
The multi-year forecast shows a structured path of gradual upside. In 2026 the average price is $3.18 with a 0% ROI, while 2027 projects an avg of $3.63 with a 14.2% ROI. The model then turns more constructive in 2028, with an avg of $3.93 and a 23.7% ROI; 2029 at $3.64 and 14.5% ROI; 2030 at $3.69 and 16% ROI.
The outlook strengthens further in 2031 at $4.37 (37.3% ROI) and 2032 at $4.80 (50.9% ROI), continuing through 2033 at $5.20 (63.5% ROI) and 2034 at $5.29 (66.5% ROI), then 2035 at $5.09 (60% ROI). The forecast remains bullish for the long horizon, with 2040 averaging $7.45 (134.3% ROI) and 2050 averaging $13.56 (326.4% ROI). Sentiment shifts from NEUTRAL in 2026-2027 to BULLISH from 2028 onward.
These are estimates, not guarantees, and reflect a long-run upside with notable uncertainty in the near term.
Tap a question to reveal the answer.
2030 avg $3.69 with min $2.76 and max $5.29; ROI 16%; sentiment NEUTRAL.
The forecast shows potential long-term upside, with 2050 avg $13.56 and ROI 326.4%, and a bullish stance from 2028 onward, but near term includes years with 0-14% ROI and NEUTRAL sentiment; these are estimates, not guarantees.
Yes, the max forecasted prices include $12.32 in 2040 and $24.43 in 2050, with earlier peaks around $8.14 in 2034 and $7.94 in 2035.
Current price is $3.18 and market cap is $326.19M.
RSI14 is 50; SMA50 is $3.23; SMA200 is $3.85; 30-day range $2.69 to $3.76; support $2.87; resistance $3.23; sentiment NEUTRAL; annualized volatility 50%.
SBC Medical Group Holdings Incorporated Community Discussion
0Share your SBC Medical Group Holdings Incorporated price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.